Nabota, a botulinum toxin type A product developed by South Korean company Daewoong Pharmaceutical, has quickly gained attention as a promising alternative to Botulinum Toxin . Launched with the promise of high purity, efficacy, and safety, Nabota has entered the global market as a serious contender